Allarity Therapeutics Stock (NASDAQ: ALLR) stock price, news, charts, stock research, profile.
Open | $0.753 |
Close | - |
Volume / Avg. | 3.053M / 2.621M |
Day Range | 0.711 - 0.770 |
52 Wk Range | 0.710 - 366.400 |
Market Cap | $1.790M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 14 |
Short Interest | 4.4% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Allarity Therapeutics (NASDAQ: ALLR) through any online brokerage.
Other companies in Allarity Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
The latest price target for Allarity Therapeutics (NASDAQ: ALLR) was reported by Ladenburg Thalmann on Tuesday, August 23, 2022. The analyst firm set a price target for 0.00 expecting ALLR to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $0.75 last updated Today at May 8, 2024 at 9:29 AM EDT.
There are no upcoming dividends for Allarity Therapeutics.
Allarity Therapeutics’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Allarity Therapeutics.
Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.